Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Epilepsy and brain tumors].

S Dupont1

  • 1Unité d'épileptologie, clinique neurologique Paul-Castaigne, hôpital de la Salpêtrière, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France. sophie.dupont@psl.ap-hop-paris.fr

Revue Neurologique
|June 21, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of long-term exposure to ocean acidification on the Patagonian scallop Zygochlamys patagonica (P.P. king, 1832), a strategic fishery resource in the Southwest Atlantic ocean.

Marine environmental research·2026
Same author

Late-onset epilepsy as a prodromal symptom.

Revue neurologique·2025
Same author

Sex-related variability of white matter tracts in the whole HCP cohort.

Brain structure & function·2024
Same author

Discriminating factors in access to video-EEG for epilepsy surgery in a French tertiary epilepsy center.

Revue neurologique·2024
Same author

Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review.

Revue neurologique·2023
Same author

Higher temperatures directly increase germ cell number, promoting feminization of red-eared slider turtles.

Current biology : CB·2023
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
Same journal

Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective.

Revue neurologique·2026
See all related articles

Epilepsy is a frequent complication of brain tumors, often proving difficult to treat due to drug resistance. Current guidelines do not support routine prophylactic antiepileptic drugs, but new research is needed.

Area of Science:

  • Neuro-oncology
  • Clinical Neurology
  • Epileptology

Context:

  • Epilepsy frequently complicates the course of patients with brain tumors, often presenting as the initial symptom.
  • Tumor type and location significantly impact seizure frequency, with certain tumor types posing a higher risk.
  • Seizures in brain tumor patients can be refractory to standard antiepileptic drug treatments.

Purpose:

  • To review the relationship between brain tumors and epilepsy, focusing on influencing factors, treatment challenges, and prophylactic strategies.
  • To discuss the role of tumor characteristics, genetic factors, and multidrug resistance in refractory epilepsy associated with brain tumors.
  • To evaluate the current evidence regarding prophylactic antiepileptic drug use and highlight the need for further research with novel antiepileptic drugs.

Related Experiment Videos

Summary:

  • Epilepsy is common in brain tumor patients, influenced by tumor type and location.
  • Drug-resistant seizures in this population are multifactorial, involving tumor biology, host factors, and oncologic treatments.
  • While prophylactic antiepileptic treatment is not routinely recommended, evidence for newer drugs is lacking, necessitating further studies.

Impact:

  • Informs clinical practice regarding the management of epilepsy in brain tumor patients.
  • Highlights the limitations of current antiepileptic drug strategies and the need for personalized treatment approaches.
  • Underscores the importance of ongoing research to develop effective prophylactic and therapeutic interventions for brain tumor-related epilepsy.